• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1993 Fiscal Year Final Research Report Summary

Syndrome of extreme insulin resistance due to decreased promoter activity of 5'-flanking region of insulin receptor gene.

Research Project

Project/Area Number 03454513
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field 内分泌・代謝学
Research InstitutionTOYAMA MEDICAL AND PHARMACERTICAL UNIVERSITY (1992-1993)
Shiga University of Medical Science (1991)

Principal Investigator

KOBAYASHI Msashi  Toyama Medical & Pharmaceutical University, Department of Medicine, Professor, 医学部, 教授 (80115758)

Co-Investigator(Kenkyū-buntansha) TAKATA Yasumitsu  Toyama Medical & Pharmaceutical University, Department of Medicine, Assistant, 医学部, 助手 (50242491)
Project Period (FY) 1991 – 1993
KeywordsInsulin Receptor / Syndrome of Extreme Insulin Resistance / Point Mutation / Tyrosine Kinase
Research Abstract

We investigated the genetic basis of nine families of syndrome of extreme insulin resistance and identified missense mutations of insulin receptor gene in six families, i.e., Arg^<735>->Ser^<735>, pro^<193>->Leu^<193>, Ala^<1048>->Asp^<1048>, Glu^<1179>->Asp^<1179> and Trp^<1193>->Leu^<1193>. The mechanisms of insulin resistance for each mutations were investigated to show as follows. Ala^<1048>->Asp^<1048> in the tyrosine kinase domain of beta subunit caused decreased tyrosine kinase activity. In other five families, decreased insulin binding was responsible for their insulin resistance. Among these mutations, Arg^<735>->Ser^<735> caused decreased insulin binding affinity and others were responsible for decreased receptor number on the cell surface, i.e., mutant insulin receptors with these mutations were not transported to the plasma membrane because of impaired processing of synthesized receptors. We have clarified a novel mechanism of decreased receptor nember in mutations Clu^<1179>->Asp^<1179> and Trp^<1193>->Leu^<1193>. When expressed in COS 7 cells, most of the mutant receptors were degraded in the biosynthetic process and only part of the receptors were able to be transported to the plasma membrane.
In another family with decreased expression of insulin receptor mRNA, we studied promoter region of insulin receptor gene and observed that nucleotide sequence in GC box around position -603 was variable in the patient and control subjects. However, promoter activity was not decreased in the case of the patient. Therefore, unidentified abnormalities in regulatory region which was not studied may responsible for the decrease expression of insulin recepotor gene.

  • Research Products

    (15 results)

All Other

All Publications (15 results)

  • [Publications] Iwanishi M,Haruta T,Takata Y,Imamura T,Kobayashi M: "Importance of ASP^<1191> for Tyrosine kinase activity of the insulin recepto:functional difference of universally conserved ASP between tyrosine kinase and c-AMP dependent serine/Threonine protein kinase" Biochem.Biophys.Res.Commun.197. 353-359 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Iwanishi M,Kobayashi M: "Effect of pioglitazone on insulin recepters of skeletal muscles from high-fat-fed rats" Metabolism. 42. 1017-1021 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Haruta T,Takata Y,Iwanishi M,Maegawa H,Imamura T,Itazu T,Kobayashi M: "Ala^<1048>→Asp mutation in the kinase domain of insulin receptor causes defective kinase activity and insulin resistance" Diabetes. 42. 1837-1844 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kuzuya H,Matsuura W,Sakamoto M,Makino H,Kobayashi M,et.al.: "Trial of insulin like growth factor I therapy for patients with extreme insulin resistance syndromes" Diabetes. 42. 696-705 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kobayashi M,Iwanishi M,et.al.: "A mutation(Trp^<1193>→Leu^<1193>)in the kinase domain of the insulin receptor associated with Type A syndrome of insulin resistance" Diabetologic. 36. 414-422 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kobayashi M,Maegawa H,et al.: "Co-expression of mutant and normal human insulin receptors in COS 7 cells" Biochem.Biophys.Acta.1216. 425-430 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sugibayashi M, Shigeta Y, Teraoka H, Kobayashi M: "Characterization of unprocessed insulin receptors in COS cells transfected with cDNA with Arg^<735>->Ser^<735> point mulation at the cleavage site" Metabolism. 41. 820-826 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kobayashi M, Iwanishi M, Egawa K, Shigeta Y: "Pioglitazone increases insulin sensitivity by activating insulin receptor kinase." Diabetes. 41. 476-483 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takata Y, Webster NJG, Olefsky JM: "Intracellular signalling by a mutant human insulin receptor lacking the carboxyterminal tyrosine autophosphoryation" J.Biol. Chem. 267. 9065-9070 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwanishi M, Haruta T, Takata Y, Imamura T, Kobayashi M: "Imprtance of Asp^<1191> for tyrosine kinase activity of the insulin receptor : functional difference of universally conserved Asp between tyrosine kinase and c-AMP dependent serine/threonine protein kinase." Biochem. Biophys. Res. Commun. 197. 353-359 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwanishi M, Kobayashi M: "Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat fed rats." Metabolism. 42. 1017-1021 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Haruta T, Takara Y, Iwanishi M, Maegawa H, Imamura T, Egawa K, Itazu T, Kobayashi M: "Ala^<1048>->Asp mutation in the kinase domain of insulin receceptor causes defective kinase activity and insulin resistance." Diabetes. 42. 1837-1844 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kuzuya H, Matsuura W, Sakamoto M, Makino H, Sakamoto Y, Kadowaki T, Suzuki Y, Kobayashi M et.al.: "Trial of insulin like growth factor I therapy for patients with extreme insulin resistance syndrome." Diabetes. 42. 696-705 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwanishi M, Haruta T, Takata Y, Ishibashi O, Sasaoka T, Egawa E, Imamura T, Naitou K, Itazu T, Kobayashi M: "A mutation (Trp^<1193>->Leu^<1193>) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance." Diabetologia. 36. 414-422 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maegawa H, Kashiwagi A, Haruta T, Egawa K, Ugi S, Tachikawa-Ide R, Hasegawa M, Kobayashi M, Shigeta Y: "Co-expression of mutant and normal human insulin receptors COS 7 cells." Biochimi. Biophys. Acta. 1216. 425-430 (1993)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1995-03-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi